$0.53
4.52% day before yesterday
Nasdaq, Nov 01, 09:00 pm CET
ISIN
US0070251097
Symbol
ADTX
Sector
Industry

Aditx Therapeutics Inc Target price 2024 - Analyst rating & recommendation

Aditx Therapeutics Inc Classifications & Recommendation:

Buy
100%

Aditx Therapeutics Inc Price Target

Target Price $2,440.00
Price $0.53
Potential
Number of Estimates 1
1 Analyst has issued a Aditx Therapeutics Inc price target 2025. The average Aditx Therapeutics Inc target price is $2,440.00. This is higher than the current stock price.
A rating was issued by 1 analysts: 1 Analysts recommend Aditx Therapeutics Inc to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Aditx Therapeutics Inc stock has an average upside potential 2025 of . Most analysts recommend the Aditx Therapeutics Inc stock at Purchase.

Sales and Margin forecast 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Dec '23 2024
Estimates
Revenue Million $ 0.65 1.48
30.11% 126.92%
Net Margin -33,277.85% -12,312.37%
939.41% 63.00%

1 Analyst has issued a sales forecast Aditx Therapeutics Inc 2024 . The average Aditx Therapeutics Inc sales estimate is

$1.5m
Unlock
. This is
346.97% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$1.5m 346.97%
Unlock
, the lowest is
$1.5m 346.97%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $650k 30.11%
2024
$1.5m 126.92%
Unlock

The average Aditx Therapeutics Inc net profit estimate is

$-182m
Unlock
. This is
28.73% lower
Unlock
than the net profit for the last 12 months(TTM).

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $-216m 626.47%
2024
$-182m 16.04%
Unlock

Net Margin

2023 -33,277.85% 939.41%
2024
-12,312.37% 63.00%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Dec '23 2024
Estimates
Earnings Per Share $ -4,326.12 -91.26
626.47% 97.89%
P/E 0.00
EV/Sales 6.31

The average Aditx Therapeutics Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$-91.26
Unlock
. This is
96.77% higher
Unlock
than earnings per share in the financial year 2023.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $-4,326.12 626.47%
2024
$-91.26 97.89%
Unlock

P/E ratio

Current 0.00 100.00%

Based on analysts' sales estimates for 2024, the Aditx Therapeutics Inc stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 37.45 419.42%
2024
6.31 83.15%
Unlock

P/S ratio

Current 14.03 880.04%
2024
1.07 92.37%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today